ARTICLE | Company News
UCSD, RetroSense Therapeutics deal
September 12, 2016 7:00 AM UTC
The university granted RetroSense exclusive, worldwide rights to develop red activatable channelrhodopsin (ReaChR), a next-generation optogene, which RetroSense will use for vision restoration. RetroS...